Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 121.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 187.00
  • 52 Week Low: 30.38
  • Currency: UK Pounds
  • Shares Issued: 59.86m
  • Volume: 4,629
  • Market Cap: 72.43m
  • RiskGrade: 410

Destiny Pharma Overview

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem of anti-microbial resistance (AMR).

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 5.8  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Destiny Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 n/a (1.45) (3.98)p n/a n/a n/a n/a 0.0%
31-Dec-17 n/a (3.21) (8.37)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (6.01) (11.85)p n/a n/a n/a n/a 0.0%
31-Dec-19 n/a (5.52) (10.66)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (6.48) (12.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Destiny Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (6.52) (8.76)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Destiny Pharma Company Announcements

Director Dealing 10-Jun-2021 17:00 RNS
XF-73 data abstract to be presented at 2021 ECCMID 10-Jun-2021 07:00 RNS
Destiny Pharma welcomes G7’s Communique on... 07-Jun-2021 07:00 RNS

Latest Destiny Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 121.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 187.00
52 Week Low 30.38
Volume 4,629
Shares Issued 59.86m
Market Cap 72.43m
RiskGrade 410

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.6% below the market average44.6% below the market average44.6% below the market average44.6% below the market average44.6% below the market average
7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average
Price Trend
90.38% above the market average90.38% above the market average90.38% above the market average90.38% above the market average90.38% above the market average
72.88% above the sector average72.88% above the sector average72.88% above the sector average72.88% above the sector average72.88% above the sector average
Income Not Available
Growth Not Available

Destiny Pharma Dividends

No dividends found

Trades for 23-Jun-2021

Time Volume / Share Price
08:43 3,500 @ 119.00p
08:17 1,129 @ 119.00p

Destiny Pharma Key Personnel

CEO Neil Clark
Chair Nick Rodgers

Top of Page